- Home
- AUTL vs NIE Comparison
AUTL vs NIE Comparison
Compare AUTL & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- NIE
- Stock Information
- Founded
- AUTL 2014
- NIE 2007
- Country
- AUTL United Kingdom
- NIE United States
- Employees
- AUTL N/A
- NIE N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- NIE Investment Managers
- Sector
- AUTL Health Care
- NIE Finance
- Exchange
- AUTL Nasdaq
- NIE Nasdaq
- Market Cap
- AUTL 590.8M
- NIE 697.4M
- IPO Year
- AUTL 2018
- NIE N/A
- Fundamental
- Price
- AUTL $1.44
- NIE $22.23
- Analyst Decision
- AUTL Strong Buy
- NIE
- Analyst Count
- AUTL 5
- NIE 0
- Target Price
- AUTL $9.32
- NIE N/A
- AVG Volume (30 Days)
- AUTL 1.3M
- NIE 70.5K
- Earning Date
- AUTL 05-13-2025
- NIE 01-01-0001
- Dividend Yield
- AUTL N/A
- NIE 9.04%
- EPS Growth
- AUTL N/A
- NIE N/A
- EPS
- AUTL N/A
- NIE N/A
- Revenue
- AUTL $10,120,000.00
- NIE N/A
- Revenue This Year
- AUTL $277.74
- NIE N/A
- Revenue Next Year
- AUTL $221.89
- NIE N/A
- P/E Ratio
- AUTL N/A
- NIE N/A
- Revenue Growth
- AUTL 496.00
- NIE N/A
- 52 Week Low
- AUTL $1.40
- NIE $18.61
- 52 Week High
- AUTL $5.84
- NIE $22.47
- Technical
- Relative Strength Index (RSI)
- AUTL 32.97
- NIE 38.10
- Support Level
- AUTL $1.58
- NIE $21.79
- Resistance Level
- AUTL $1.70
- NIE $22.86
- Average True Range (ATR)
- AUTL 0.13
- NIE 0.40
- MACD
- AUTL -0.02
- NIE 0.05
- Stochastic Oscillator
- AUTL 3.03
- NIE 45.22
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments such as aerospace and defense, banks, IT services, software, and others.